Sensei biotherapeutics to present at upcoming conferences

Boston, sept. 04, 2024 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that company management will present at the following conferences in september 2024:
SNSE Ratings Summary
SNSE Quant Ranking